Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Dec 16, 2010
ecent advances in biomedical engineering have had transformative impacts, particularly in designing drugs and therapies for personalizing health care on an individualized basis. But the path to achieving the full potential of these technologies depends on public policy and economic constraints of the health care system. Jim Collins, a professor of biomedical engineering in the College of Engineering, recipient of the MacArthur Foundation "Genius" Award, and BU's first Howard Hughes Medical Institute Investigator, along with George Savage (ENG'81), cofounder and chief medical officer of Proteus Biomedical, discuss these implications at ENG's third annual Future of Engineering Symposium.
Hosted by the College of Engineering on October 29, 2010.